Its two RLT products Lutathera (lutetium-177 DOTATATE) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and Pluvicto (lutetium-177 PSMA-617) for metastatic castration-resistant prostate cancer represent the most commercially advanced radioligand therapy platform in the world and occupy the Oncology Peptide Therapy segment, which the report forecasts to grow at 11.79% CAGR through 2031
[DOI] [PubMed] [Google Scholar] 19.Bertrand E., Lewandowska E., Szpak G.M., Hoogenraad T., Blaauwgeers H.G., Czonkowska A., Dymecki J
At Vytality Blu Health & Medspa, we are committed to helping you achieve your weight loss and wellness goals through personalized, medically supervised programs
The powder requires reconstitution with bacteriostatic water before administration
Together, these peptides represent two complementary areas of regenerative research while maintaining their own independent scientific evidence base